Article Text

PDF
MMR: where are we now?
  1. David Elliman1,
  2. Helen Bedford2
  1. 1
    Islington PCT and Great Ormond Street Hospital for Children, Great Ormond Street, London, UK
  2. 2
    Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, London, UK
  1. David Elliman, Great Ormond Street Hospital for Children, Great Ormond Street, London WC1N 3JH, UK; ellimd{at}gosh.nhs.uk

Statistics from Altmetric.com

There is no scientific evidence of a link between bowel disease and/or autism and MMR vaccine. Attainment of a high uptake of the vaccine should be encouraged.

The combined measles, mumps and rubella (MMR) vaccine was introduced to the UK in 1988 and uptake of the vaccine rose rapidly to a high of 92%. In 1992, brands containing the Urabe strain of the mumps vaccine virus were withdrawn after it was noted to be associated with an increased risk of aseptic meningitis.1 This did not appear to have a deleterious effect on uptake. In 1995, a paper was published suggesting a link between measles vaccines and the development of bowel disorders in adulthood.2 This was associated with a small decline in the uptake of MMR vaccine. In 1998, the same group of researchers published observations of 12 children with pervasive developmental disorders and bowel disease and suggested that the latter may have led to the former.3 In eight children, the history of the onset of symptoms coincided with receipt of MMR vaccine. Although the researchers stated in the paper that “we did not prove an association between measles, mumps, and rubella vaccine and the syndrome described”, and an accompanying commentary was heavily critical of any suggestion of such a link,4 the story attracted much attention in the media. This was largely fuelled by a paragraph in the press release accompanying a press conference: “The majority opinion among the researchers involved in this study supports the continuation of MMR vaccination. Dr Wakefield feels that vaccination against the measles, mumps, and rubella infections should undoubtedly continue but until this issue is resolved by further research there is a case for separating the three vaccines into separate measles, mumps, and rubella components and giving them individually spaced by at …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Précis
    BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
  • Atoms
    Howard Bauchner